These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27442500)

  • 1. Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.
    Brusse-Keizer M; Klatte M; Zuur-Telgen M; Koehorst-Ter Huurne K; van der Palen J; VanderValk P
    COPD; 2017 Feb; 14(1):7-14. PubMed ID: 27442500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
    Han MZ; Hsiue TR; Tsai SH; Huang TH; Liao XM; Chen CZ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3425-3433. PubMed ID: 30425472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
    Kim J; Lee CH; Hwang SS; Kim DK; Yoon HI; Lee SH; Kim KU; Kim EK; Kim TH; Lee JH; Oh YM; Lee SD
    Respiration; 2019; 98(6):495-502. PubMed ID: 31665736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study.
    Bhatta L; Leivseth L; Mai XM; Henriksen AH; Carslake D; Chen Y; Langhammer A; Brumpton BM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():225-233. PubMed ID: 32099347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
    Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
    Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort.
    Le LAK; Johannessen A; Hardie JA; Johansen OE; Gulsvik A; Vikse BE; Bakke P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1639-1655. PubMed ID: 31413559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study.
    Plutinsky M; Brat K; Svoboda M; Zatloukal J; Popelkova P; Koblizek V
    Lung; 2019 Apr; 197(2):173-179. PubMed ID: 30694380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.
    Marçôa R; Rodrigues DM; Dias M; Ladeira I; Vaz AP; Lima R; Guimarães M
    COPD; 2018 Feb; 15(1):21-26. PubMed ID: 29161163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Clinical COPD Questionnaire in Taiwan.
    Lin WC; Huang TY; Liu CY; Yeh ML; Yu CH; Hwang SL
    COPD; 2016 Jun; 13(3):360-6. PubMed ID: 26678264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
    Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
    Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
    Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.
    Faner R; Noell G; Badia JR; López-Giraldo A; Bakke P; Silverman EK; Tal-Singer R; Agustí A
    Respir Med; 2018 Aug; 141():14-19. PubMed ID: 30053959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.